#1 Clinical Trials Search in Europe

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

  • Study of sildenafil to improve walking distance in patients with peripheral arterial disease and intermittent claudication

    Not recruiting

    1 1 1
    Investigated drugs:
    France

  • Preventing Neovascular Glaucoma in Patients with Large Choroidal Melanoma Using Aflibercept During Proton Therapy

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study of Relatlimab, Nivolumab, and 5-Azacytidine for Acute Myeloid Leukemia in Patients Not Eligible for Intensive Chemotherapy

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study on the Safety of ATreg Cells for Patients with Leukemia After Stem Cell Transplant to Reduce Graft vs Host Disease

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study of Insulin Treatment for Blood Glucose Control in Adult Critically Ill Patients with Stress Hyperglycemia

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Belgium

  • Study on Long-Term Safety and Efficacy of Cebsulfase Alfa for Children with Late Metachromatic Leukodystrophy Receiving Intrathecal Enzyme Replacement

    Not recruiting

    1 1
    Investigated drugs:
    Czechia Denmark France Germany Italy

  • Study on the Effects of VCN-01 with Nab-Paclitaxel and Gemcitabine for Patients with Advanced Pancreatic Cancer

    Not recruiting

    1 1
    Investigated drugs:
    Spain

  • Study of Mosunetuzumab and Zanubrutinib for Patients with Relapsed or Refractory Follicular Lymphoma

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study of ACP-017 and Pembrolizumab for Patients with Advanced or Metastatic Cancer

    Not recruiting

    1 1 1
    Investigated drugs:
    The Netherlands Spain

  • Study on the Effect of Extending Imatinib Treatment from Three to Five Years for Patients with High-Risk Gastrointestinal Stromal Tumor (GIST)

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Austria Denmark Finland Germany The Netherlands Norway +2